Active-ingredient Dossier
Pertactin
Active-ingredient Dossier for Pertactin (acellular pertussis vaccine component). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: VAXELIS
- Brand: ADACEL
- Brand: BOOSTRIX
- Brand: BOOSTRIX-IPV
- Brand: INFANRIX
- Brand: INFANRIX-IPV
- Therapeutic area: Infectious Disease
What is
Pertactin Pertactin is an acellular pertussis vaccine component.
Australian brands containing
Pertactin — ADACEL — BOOSTRIX — BOOSTRIX-IPV — INFANRIX — INFANRIX-IPV — QUADRACEL — TRIPACEL — VAXELIS
Therapeutic areas
Pertactin is registered in two therapeutic areas: Infectious Disease, with seven brands, and Immunology, with one brand.
Sponsor landscape
Three sponsors market pertactin-containing products: GlaxoSmithKline, Sanofi-Aventis, and Maxx Pharma.
PBS and regulatory activity
Two brands containing pertactin have PBAC outcomes on record, with the latest PBAC outcome dated 1 March 2017. No AusPARs are on record for pertactin-containing products.